 Marijuana Abuse
"Marijuana Abuse" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The excessive use of marijuana with associated psychological symptoms and impairment in social or occupational functioning.
| Descriptor ID |
D002189
|
| MeSH Number(s) |
C25.635 F03.900.635
|
| Concept/Terms |
Marijuana Abuse- Marijuana Abuse
- Abuse, Marijuana
- Marihuana Abuse
- Abuse, Marihuana
Cannabis Dependence- Cannabis Dependence
- Dependence, Cannabis
- Marijuana Dependence
- Dependence, Marijuana
|
Below are MeSH descriptors whose meaning is more general than "Marijuana Abuse".
Below are MeSH descriptors whose meaning is more specific than "Marijuana Abuse".
This graph shows the total number of publications written about "Marijuana Abuse" by people in UAMS Profiles by year, and whether "Marijuana Abuse" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 1 | 2 | | 2023 | 6 | 0 | 6 | | 2022 | 5 | 0 | 5 | | 2021 | 4 | 0 | 4 | | 2020 | 4 | 0 | 4 | | 2019 | 5 | 0 | 5 | | 2018 | 4 | 3 | 7 | | 2017 | 7 | 0 | 7 | | 2016 | 5 | 2 | 7 | | 2015 | 6 | 2 | 8 | | 2014 | 2 | 1 | 3 | | 2013 | 3 | 0 | 3 | | 2012 | 7 | 1 | 8 | | 2011 | 3 | 0 | 3 | | 2010 | 6 | 2 | 8 | | 2009 | 3 | 0 | 3 | | 2008 | 6 | 1 | 7 | | 2007 | 2 | 0 | 2 | | 2006 | 4 | 2 | 6 | | 2005 | 2 | 0 | 2 | | 2004 | 2 | 0 | 2 | | 2003 | 2 | 0 | 2 | | 2002 | 2 | 0 | 2 | | 2001 | 2 | 0 | 2 | | 2000 | 1 | 0 | 1 | | 1999 | 1 | 1 | 2 | | 1998 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1994 | 0 | 1 | 1 | | 1991 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Marijuana Abuse" by people in Profiles over the past ten years.
-
Collins AC, Bhattacharya S, Oh JY, Salzhauer A, Taylor CT, Wolitzky-Taylor K, Aupperle RL, Budney AJ, Jacobson NC. Inclusion of Individuals With Lived Experiences in the Development of a Digital Intervention for Co-Occurring Depression and Cannabis Use: Mixed Methods Investigation. JMIR Form Res. 2024 Oct 07; 8:e54751.
-
Volkow ND, Compton WM, Blanco C, Einstein EB, Han B. Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States. Int J Drug Policy. 2024 Jun; 128:104431.
-
Lee DC, Schlienz NJ, Herrmann ES, Martin EL, Leoutsakos J, Budney AJ, Smith MT, Tompkins DA, Hampson AJ, Vandrey R. Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder. J Subst Use Addict Treat. 2024 01; 156:209180.
-
Struble CA, Borodovsky JT, Habib MI, Livne O, Walsh CA, Aharonovich E, Hasin DS, Budney AJ. Evaluating age-related disparities in cannabis-related problems among LGBT+?versus non-LGBT+?adults. Addict Behav. 2024 01; 148:107861.
-
Struble CA, Borodovsky JT, Habib MI, Hasin DS, Shmulewitz D, Livne O, Walsh C, Aharonovich E, Budney AJ. Extending Gender- and Sex-Based Analyses in Cannabis Research: Findings from an Online Sample of Gender Diverse Young Adult Consumers. Cannabis Cannabinoid Res. 2024 Dec; 9(6):e1604-e1614.
-
Haney M, Vall?e M, Fabre S, Collins Reed S, Zanese M, Campistron G, Arout CA, Foltin RW, Cooper ZD, Kearney-Ramos T, Metna M, Justinova Z, Schindler C, Hebert-Chatelain E, Bellocchio L, Cathala A, Bari A, Serrat R, Finlay DB, Caraci F, Redon B, Mart?n-Garc?a E, Busquets-Garcia A, Matias I, Levin FR, Felpin FX, Simon N, Cota D, Spampinato U, Maldonado R, Shaham Y, Glass M, Thomsen LL, Mengel H, Marsicano G, Monlezun S, Revest JM, Piazza PV. Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nat Med. 2023 Jun; 29(6):1487-1499.
-
Shmulewitz D, Budney AJ, Borodovsky JT, Bujno JM, Walsh CA, Struble CA, Livne O, Habib MI, Aharonovich E, Hasin DS. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. J Psychiatr Res. 2023 07; 163:211-221.
-
Beckham JC, Calhoun PS, Chen Z, Dennis MF, Kirby AC, Treis ET, Hertzberg JS, Hair LP, Mann AJ, Budney AJ, Kimbrel NA. Development of Mobile Contingency Management for Cannabis Use Reduction. Behav Ther. 2024 Jan; 55(1):1-13.
-
Barbotin B, Hoertel N, Olfson M, Blanco C, Sanchez-Rico M, Lejoyeux M, Limosin F, Geoffroy PA. Sleep Complaints Among Adults With Major Depressive Episode Are Associated With Increased Risk of Incident Psychiatric Disorders: Results From a Population-Based 3-Year Prospective Study. J Clin Psychiatry. 2022 12 21; 84(1).
-
Desai R, Jain A, Sultan W, Gandhi Z, Raju AR, Varughese VJ, Jnaneswaran G, Agarwal C, Rizvi B, Mansuri Z, Gupta P, Kumar G, Sachdeva R. Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis. Medicina (Kaunas). 2022 Oct 16; 58(10).
-
McCarty TR, Chouairi F, Hathorn KE, Chan WW, Thompson CC. Trends and Socioeconomic Health Outcomes of Cannabis Use Among Patients With Gastroparesis: A United States Nationwide Inpatient Sample Analysis. J Clin Gastroenterol. 2022 04 01; 56(4):324-330.
-
Borodovsky JT, Sofis MJ, Sherman BJ, Gray KM, Budney AJ. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints. Psychol Addict Behav. 2022 Aug; 36(5):515-525.
-
Connor JP, Stjepanovic D, Budney AJ, Le Foll B, Hall WD. Clinical management of cannabis withdrawal. Addiction. 2022 07; 117(7):2075-2095.
-
Sherman BJ, Sofis MJ, Borodovsky JT, Gray KM, McRae-Clark AL, Budney AJ. Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder. Psychol Addict Behav. 2022 Aug; 36(5):505-514.
-
Kearney-Ramos T, Haney M. Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2021 07 13; 109:110290.
-
Connor JP, Stjepanovic D, Le Foll B, Hoch E, Budney AJ, Hall WD. Cannabis use and cannabis use disorder. Nat Rev Dis Primers. 2021 02 25; 7(1):16.
-
Budney AJ. Teen Reports of Cannabis for Medical Reasons-What Does That Mean? J Adolesc Health. 2021 01; 68(1):9-10.
-
Winters KC, Mader J, Budney AJ, Stanger C, Knapp AA, Walker DD. Interventions for cannabis use disorder. Curr Opin Psychol. 2021 04; 38:67-74.
-
Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, McRae-Clark AL, Montoya I, Peters EN, Ramey T, Turk DC, Vandrey R, Weiss RD, Strain EC. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug Alcohol Depend. 2020 07 01; 212:107993.
-
Sofis MJ, Lemley SM, Lee DC, Budney AJ. A web-based episodic specificity and future thinking session modulates delay discounting in cannabis users. Psychol Addict Behav. 2020 Jun; 34(4):532-540.
-
Lee SW, Shen J, Kim SJ, Chun SY, Kim P, Riaz J, Yoo JW, Hwang J. US Trends of Opioid-use Disorders and Associated Factors Among Hospitalized Patients With Spinal Conditions and Treatment From 2005 to 2014. Spine (Phila Pa 1976). 2020 Jan 15; 45(2):124-133.
-
Sofis MJ, Budney AJ, Stanger C, Knapp AA, Borodovsky JT. Greater delay discounting and cannabis coping motives are associated with more frequent cannabis use in a large sample of adult cannabis users. Drug Alcohol Depend. 2020 02 01; 207:107820.
-
Compton WM, Han B, Jones CM, Blanco C. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Drug Alcohol Depend. 2019 11 01; 204:107468.
-
Patel RS, Kamil SH, Bachu R, Adikey A, Ravat V, Kaur M, Tankersley WE, Goyal H. Marijuana use and acute myocardial infarction: A systematic review of published cases in the literature. Trends Cardiovasc Med. 2020 07; 30(5):298-307.
-
Sofis MJ, Lemley SM, Budney AJ, Stanger C, Jarmolowicz DP. Persisting on the past: Cross-sectional and prospective associations between sunk cost propensity and cannabis use. Exp Clin Psychopharmacol. 2020 Apr; 28(2):225-234.
-
Fairman BJ, Furr-Holden CD, Johnson RM. When Marijuana Is Used before Cigarettes or Alcohol: Demographic Predictors and Associations with Heavy Use, Cannabis Use Disorder, and Other Drug-related Outcomes. Prev Sci. 2019 02; 20(2):225-233.
-
Budney AJ, Sofis MJ, Borodovsky JT. An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. Eur Arch Psychiatry Clin Neurosci. 2019 Feb; 269(1):73-86.
-
Han B, Compton WM, Blanco C, Jones CM. Time since first cannabis use and 12-month prevalence of cannabis use disorder among youth and emerging adults in the United States. Addiction. 2019 04; 114(4):698-707.
-
Lee DC, Walker DD, Hughes JR, Brunette MF, Scherer E, Stanger C, Etter JF, Auty S, Budney AJ. Sequential and simultaneous treatment approaches to cannabis use disorder and tobacco use. J Subst Abuse Treat. 2019 03; 98:39-46.
-
Wall MM, Liu J, Hasin DS, Blanco C, Olfson M. Use of marijuana exclusively for medical purposes. Drug Alcohol Depend. 2019 02 01; 195:13-15.
-
Brevers D, Bechara A, Kilts CD, Antoniali V, Bruylant A, Verbanck P, Kornreich C, No?l X. Competing Motivations: Proactive Response Inhibition Toward Addiction-Related Stimuli in Quitting-Motivated Individuals. J Gambl Stud. 2018 Sep; 34(3):785-806.
-
Blanco C, Fl?rez-Salamanca L, Secades-Villa R, Wang S, Hasin DS. Predictors of initiation of nicotine, alcohol, cannabis, and cocaine use: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Am J Addict. 2018 09; 27(6):477-484.
-
Schlienz NJ, Lee DC, Stitzer ML, Vandrey R. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Drug Alcohol Depend. 2018 06 01; 187:254-260.
-
Fantegrossi WE, Wilson CD, Berquist MD. Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems. Drug Metab Rev. 2018 Feb; 50(1):65-73.
-
George N, Harrell SM, Rhodes KD, Duarte-Rojo A. Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy. Ann Hepatol. 2018 January-February; 17(1):76-84.
-
Knapp AA, Babbin SF, Budney AJ, Walker DD, Stephens RS, Scherer EA, Stanger C. Psychometric assessment of the marijuana adolescent problem inventory. Addict Behav. 2018 04; 79:113-119.
-
Beckham JC, Adkisson KA, Hertzberg J, Kimbrel NA, Budney AJ, Stephens RS, Moore SD, Calhoun PS. Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking. Addict Behav. 2018 04; 79:86-92.
-
Han B, Compton WM, Jones CM, Blanco C. Cannabis Use and Cannabis Use Disorders Among Youth in the United States, 2002-2014. J Clin Psychiatry. 2017 Nov/Dec; 78(9):1404-1413.
-
Olfson M, Wall MM, Liu SM, Blanco C. Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States. Am J Psychiatry. 2018 01 01; 175(1):47-53.
-
Budney AJ, Borodovsky JT. The potential impact of cannabis legalization on the development of cannabis use disorders. Prev Med. 2017 Nov; 104:31-36.
-
Rabin RA, Kozak K, Zakzanis KK, Remington G, Stefan C, Budney AJ, George TP. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophr Res. 2018 04; 194:47-54.
-
Compton WM, Han B, Hughes A, Jones CM, Blanco C. Use of Marijuana for Medical Purposes Among Adults in the United States. JAMA. 2017 01 10; 317(2):209-211.
-
House SJ, Coker JL, Stowe ZN. Perinatal Substance Abuse: At the Clinical Crossroads of Policy and Practice. Am J Psychiatry. 2016 11 01; 173(11):1077-1080.
-
Schuster RM, Hanly A, Gilman J, Budney A, Vandrey R, Evins AE. A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users. Drug Alcohol Depend. 2016 Oct 01; 167:199-206.
-
Osazuwa-Peters N, Adjei-Boakye E, Loux TM, Varvares MA, Schootman M. Insufficient Evidence to Support or Refute the Association between Head and Neck Cancer and Marijuana Use. J Evid Based Dent Pract. 2016 Jun; 16(2):127-9.
-
Babbin SF, Stanger C, Scherer EA, Budney AJ. Identifying treatment response subgroups for adolescent cannabis use. Addict Behav. 2016 08; 59:72-9.
-
Blanco C, Hasin DS, Wall MM, Fl?rez-Salamanca L, Hoertel N, Wang S, Kerridge BT, Olfson M. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. JAMA Psychiatry. 2016 Apr; 73(4):388-95.
-
Hughes JR, Naud S, Budney AJ, Fingar JR, Callas PW. Attempts to stop or reduce daily cannabis use: An intensive natural history study. Psychol Addict Behav. 2016 05; 30(3):389-97.
-
Marzell M, Sahker E, Pro G, Arndt S. A brief report on Hispanic youth marijuana use: Trends in substance abuse treatment admissions in the United States. J Ethn Subst Abuse. 2017 Apr-Jun; 16(2):155-164.
-
Budney AJ, Sargent JD, Lee DC. Vaping cannabis (marijuana): parallel concerns to e-cigs? Addiction. 2015 Nov; 110(11):1699-704.
-
Lee DC, Budney AJ, Brunette MF, Hughes JR, Etter JF, Stanger C. Outcomes from a computer-assisted intervention simultaneously targeting cannabis and tobacco use. Drug Alcohol Depend. 2015 Oct 01; 155:134-40.
-
Booth BM, Wright PB, Ounpraseuth ST, Stewart KE. Trajectory of substance use after an HIV risk reduction intervention. Am J Drug Alcohol Abuse. 2015; 41(4):345-52.
-
Budney AJ, Stanger C, Tilford JM, Scherer EB, Brown PC, Li Z, Li Z, Walker DD. Computer-assisted behavioral therapy and contingency management for cannabis use disorder. Psychol Addict Behav. 2015 Sep; 29(3):501-11.
-
Stanger C, Ryan SR, Scherer EA, Norton GE, Budney AJ. Clinic- and home-based contingency management plus parent training for adolescent cannabis use disorders. J Am Acad Child Adolesc Psychiatry. 2015 Jun; 54(6):445-53.e2.
-
Fairman BJ. Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts. Drug Alcohol Depend. 2015 May 01; 150:77-84.
-
Cochran G, Stitzer M, Campbell AN, Hu MC, Vandrey R, Nunes EV. Web-based treatment for substance use disorders: differential effects by primary substance. Addict Behav. 2015 Jun; 45:191-4.
-
Lee DC, Stanger C, Budney AJ. A comparison of delay discounting in adolescents and adults in treatment for cannabis use disorders. Exp Clin Psychopharmacol. 2015 Apr; 23(2):130-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|